Riken eyes iPS clinical research

Riken eyes iPS clinical research

KOBE, Japan - Masayo Takahashi (L), an ophthalmologist who heads Riken's research team on retinal regeneration at the Riken Center for Development Biology, speaks during a press conference in Kobe, western Japan, on Feb. 28, 2013. Riken, Japan's state-backed scientific research institute, applied for government permission the same day for its plan to conduct clinical research using induced pluripotent stem cells, known as iPS cells, to regenerate retina.

  • Product Code
  • ILEA001179773
  • Registered date
  • 2013/2/28 00:00:00
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • 2013 Kyodo News
  • Media size
  • 3886 × 2806 pixel
  • Resolution
  • 240 dpi
  • Deployment size
  • 846.92(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    Riken eyes iPS clinical research

    Riken eyes iPS clinical research

    KOBE, Japan - Masayo Takahashi (L), an ophthalmologist who heads Riken's research team on retinal regeneration at the Riken Center for Development Biology, speaks during a press conference in Kobe, western Japan, on Feb. 28, 2013. Riken, Japan's state-backed scientific research institute, applied for government permission the same day for its plan to conduct clinical research using induced pluripotent stem cells, known as iPS cells, to regenerate retina.
      Nobel laureate visits minister

      Nobel laureate visits minister

      TOKYO, Japan - Kyoto University professor Shinya Yamanaka (L), a 2012 Nobel Prize in medicine laureate, visits education minister Hakubun Shimomura (R) at the ministry in Tokyo on Jan. 10, 2013. The minister pledged government support of 110 billion yen over 10 years for research on induced pluripotent stem cells, or iPS cells.